Dark

Check out our Dark Pool Levels

TWST
Twist Bioscience Corporation Common Stock
stock NASDAQ

Sep 18, 2026

167.01USD+7.361%(+11.45)3,069,070

Pre-market

0.00USD0.000%(0.00)0

After-hours

0.00USD0.000%(0.00)0

OverviewOptionsHistoricalExchangesShortsNews

Jan 25, 2022

08:10AM EST Twist Bioscience Signs Collaboration With Artisan Bio To Engineer Next Generation Cell Therapeutics Benzinga

Jan 20, 2022

08:00AM EST Twist Bioscience to Report Fiscal 2022 First Quarter Financial Results on Friday, February 4, 2022 Business Wire

Jan 10, 2022

08:05AM EST Twist Bioscience's Comprehensive DNA Synthesis Capabilities Expanded As Industry-Leading Enzymatic Synthesis Process Unveiled At Annual J.P. Morgan Healthcare Conference Benzinga

Jan 5, 2022

08:22AM EST Revelar Biotherapeutics, Twist Biosciences Announce RBT-0813 Neutralizes Omicron, Delta Variants Benzinga

Jan 4, 2022

08:00AM EST Twist Bioscience to Present at the 40th Annual J.P. Morgan Healthcare Conference Business Wire

Dec 20, 2021

08:03AM EST Twist Bioscience Launches 96-Plex Library Prep Kit Benzinga

Dec 16, 2021

07:35AM EST -- Collaboration aims to combine Twists proprietary synthetic antibody libraries and sophisticated bioinformatics expertise with Sosei Heptares world-leading StaR (stabilized receptor) platform to generate novel antibody leads to disease-relevant GPCR targets GlobeNewswire Inc

07:32AM EST Sosei Heptares Enters Antibody Discovery Agreement With Twist Bioscience To Discover And Develop Novel Therapeutic Antibodies Against GPCR Targets Benzinga

Dec 15, 2021

08:12AM EST Twist Bioscience Reports Is Now Shipping Synthetic RNA Positive Controls For Omicron Variant For Development Of Accurate Diagnostic Tests Benzinga

Dec 7, 2021

08:10AM EST Twist Bioscience Launches Circulating Tumor DNA Reference Controls For Development Of Liquid Biopsy Assays Benzinga

Nov 24, 2021

08:09AM EST Twist Bioscience CEO Will Present At 2 Upcoming Conferences: Piper Sandler Healthcare Conference Nov. 29 At 10 a.m. EST, Evercore ISI HealhCONx Conference Nov. 30 At 10:30 a.m. ET Benzinga

08:00AM EST Twist Bioscience to Present at Upcoming Virtual Conferences Business Wire

Nov 22, 2021

07:38AM EST Twist Bioscience To Acquire Abveris For $190M Benzinga

07:35AM EST Twist Bioscience Sees Q1 Sales $37M-$39M Vs. $38.78M Est., FY22 Sales $183M-$193M Vs. $176.65M Est. Benzinga

07:33AM EST Twist Bioscience Q4 EPS $(0.84) Misses $(0.79) Estimate, Sales $38.00M Beat $37.02M Estimate Benzinga

03:54AM EST Earnings Scheduled For November 22, 2021 Benzinga

Nov 21, 2021

03:05PM EST The Week Ahead In Biotech (Nov. 21-Nov. 27): Takeda, Aadi, Fennec FDA Decisions, Earnings In The Spotlight In Holiday-Shortened Week Benzinga

Nov 19, 2021

11:30AM EST Earnings Preview For Twist Bioscience Benzinga

Nov 18, 2021

08:05AM EST Twist Bioscience Expands Partnership With Invetx To Include Discovery Of Best-In-Class Antibodies To Treat Multiple Diseases In Cats And Dogs Benzinga

Nov 9, 2021

08:00AM EST Twist Bioscience to Present at the Stifel 2021 Virtual Healthcare Conference Business Wire

Nov 1, 2021

08:00AM EDT Twist Bioscience to Report Fiscal 2021 Fourth Quarter and Full Year Financial Results on Monday, November 22, 2021 Business Wire

Oct 13, 2021

01:38PM EDT Twist Bioscience, Broad Institute Report Creation Of Custom Whole Exome Target Enrichment Panel For Clinical Research Benzinga

Oct 6, 2021

03:50PM EDT Centogene, Twist Join Forces For Custom Test Kits For Rare Diseases Benzinga

08:06AM EDT Centogene, Twist Bioscience Report Contract To Collab On Development, Commercialization Of Custom Assay Kits For Rare Diseases, No Terms Disclosed Benzinga

08:00AM EDT CENTOGENE and Twist Bioscience to Develop Advanced Sequencing GlobeNewswire Inc

Oct 5, 2021

08:26AM EDT Twist Bioscience Reports Expansion Of Its Alliance Panel Product Offering Benzinga

Sep 23, 2021

02:03PM EDT Twist Bioscience Says Internally-Discovered Single Domain Antibody TB202-3 Shows Potent Binding To Multiple Strains Of SARS-CoV-2, Including Alpha, Beta, And Gamma Strains, In Preclinical Studies Benzinga

08:05AM EDT Twist Bioscience Collaborates With Deep Learning Experts deepCDR On Antibody Library Design Benzinga

Sep 14, 2021

08:01AM EDT Twist Bioscience Announces Has Started Shipping Its Synthetic RNA Reference Controls For SARS-CoV-2 AY.1 And AY.2 Benzinga

Sep 9, 2021

09:14AM EDT Boehringer Ingelheim and Twist Bioscience Enter Therapeutic Antibody Discovery Collaboration Benzinga

Sep 8, 2021

08:00AM EDT Twist Bioscience to Present at Baird 2021 Global Healthcare Conference Business Wire

Aug 18, 2021

12:15PM EDT Twist Bioscience, SomaLogic Team Up For Antibodies, Target Discovery Benzinga

08:30AM EDT SomaLogic And Twist Bioscience Partner To Discover Novel Therapeutic Targets And Antibodies RTTNews

08:06AM EDT Somalogic And Twist Bioscience Corporation Announce Partnership To Discover Novel Therapeutic Targets And Antibodies Benzinga

08:00AM EDT SomaLogicand Twist Bioscience Corporation announce GlobeNewswire Inc

Aug 6, 2021

07:59AM EDT Twist Bioscience: Q3 Earnings Insights Benzinga

07:42AM EDT The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO Benzinga

07:41AM EDT Twist Bioscience Raises FY21 Sales Guidance From Sales $121M-$129M To $129M-$132M vs $127.12M Est. Benzinga

07:40AM EDT Twist Bioscience Q3 EPS $(0.82) Misses $(0.75) Estimate, Sales $35.00M Beat $32.27M Estimate Benzinga

04:22AM EDT Earnings Scheduled For August 6, 2021 Benzinga

Aug 5, 2021

11:07AM EDT Earnings Outlook For Twist Bioscience Benzinga

Aug 1, 2021

11:19AM EDT The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs Benzinga

Jul 26, 2021

08:05AM EDT Twist Bioscience Incorporates MOLCURE AI Technology to Augment Therapeutic Antibody Discovery Benzinga

Jul 22, 2021

08:28AM EDT Twist Bioscience SAYS Now Shipping Synthetic RNA Positive Controls For Delta SARS-CoV-2 Variant For Development Of Accurate Diagnostic Tests Benzinga

Jul 21, 2021

08:00AM EDT Twist Bioscience to Report Fiscal 2021 Third Quarter Financial Results on Friday, August 6, 2021 Business Wire

Jun 30, 2021

11:21AM EDT Twist Bioscience Scoops Up NGS Library Prep Tools Developer For $35M Benzinga

08:17AM EDT Twist Bioscience Acquires NGS Library Preparation Maker iGenomX; Terms Not Disclosed Benzinga

Jun 29, 2021

10:53AM EDT William Blair Initiates Coverage On Twist Bioscience with Outperform Rating Benzinga

Jun 16, 2021

08:25AM EDT Dovetail Genomics Announces Availability Of New Line Of Capture Hi-C Technology RTTNews

08:06AM EDT Dovetail Genomics Announces New Capture Hi-C Targeted Enrichment Panels; Solution Incorporates Twist Bioscience's Targeted Enrichment Technology Benzinga

08:01AM EDT Dovetail Genomics Announces New Capture Hi-C Targeted Enrichment Panels PR Newswire

Jun 14, 2021

08:05AM EDT Twist Bioscience Collaborates With Regeneron For Production Of Genotyping By Sequencing Panel To Enable Diverse Genome-Wide Screening; Terms Not Disclosed Benzinga

Jun 8, 2021

08:14AM EDT Twist Bioscience Begins Shipping Of Synthetic RNA Controls For Kappa SARS-CoV-2 Variants Benzinga

Jun 4, 2021

10:03AM EDT Benzinga's Top Ratings Upgrades, Downgrades For June 4, 2021 Benzinga

06:30AM EDT Goldman Sachs Initiates Coverage On Twist Bioscience with Neutral Rating, Announces Price Target of $110 Benzinga

May 25, 2021

08:05AM EDT Twist Bioscience Highlights Launch Of Enzymatic Fragmentation Library Prep Kit For High Uniformity, High-Yield Amplification, Streamlined Next Generation Sequencing Workflow for Targeted Applications Benzinga

May 7, 2021

11:10AM EDT Twist Bioscience Q2 EPS $(0.78) Misses $(0.77) Estimate, Sales $31.2M Beats $28.32M Estimate Benzinga

11:10AM EDT CORRECTION: Twist Bioscience Q2 EPS $(0.78) Misses $(0.77) Estimate, Sales $31.2M Beats $28.32M Estimate Benzinga

May 6, 2021

04:27PM EDT Twist Bioscience Corporation Sees FY21 Sales $121M-$129M vs $120.21M Est. Benzinga

04:26PM EDT Twist Bioscience Q2 EPS $(0.78) Misses $(0.77) Estimate, Sales $3.13M Miss $28.32M Estimate Benzinga

07:49AM EDT The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom Benzinga

04:17AM EDT Earnings Scheduled For May 6, 2021 Benzinga

Apr 14, 2021

08:14AM EDT Twist Bioscience Reports Pure Biologics Selects Co. To Expand Phage Display Technology Capabilities Benzinga

Apr 12, 2021

10:04AM EDT Benzinga's Top Ratings Upgrades, Downgrades For April 12, 2021 Benzinga

08:21AM EDT Twist Bioscience Says Exercises Option To Purchase Custom Designed Antibody Library and Optimization Software Benzinga

06:01AM EDT Piper Sandler Initiates Coverage On Twist Bioscience with Overweight Rating, Announces Price Target of $150 Benzinga

Apr 9, 2021

12:25PM EDT Ginkgo Bioworks, Which Prints DNA And Creates Genetically Modified Food, Exploring SPAC Deal: Report Benzinga

Apr 8, 2021

09:29AM EDT Twist Bioscience Wednesday Said AcrodMed Selects Co's Technology To Power Next Generation Precision Medicine Tests Benzinga

09:29AM EDT Twist Bioscience Says AcrodMed Selects Co's Technology To Power Next Generation Precision Medicine Tests Benzinga

Apr 7, 2021

08:12AM EDT Twist Bioscience Reports Signed Deal 'enabling multiple academic laboratories at Stanford University to access Twist Bioscience's innovative antibody discovery and optimization services' Benzinga

Apr 5, 2021

08:00AM EDT Twist Bioscience Earns 2021 Great Place to Work Certification(tm) Business Wire

Mar 24, 2021

08:01AM EDT Twist Bioscience And Biotia Receive US FDA Emergency Use Authorization For First Hybridization Capture-Based Next-Generation Sequencing SARS-CoV-2 Assay Benzinga

Mar 22, 2021

08:17AM EDT Twist Bioscience Functional GLP-1R Antibodies Identified From Its Proprietary Synthetic DNA GPCR Libraries Demonstrate Potent Blood Glucose Control Benzinga

Mar 2, 2021

08:14AM EST Twist Bioscience, Watchmaker Genomics Report Partnership For New Applications Of High-Throughput Genetic Sequencing Benzinga

Feb 24, 2021

11:06AM EST Twist Bioscience Launches Methylation Detection Systems Benzinga

Feb 22, 2021

05:33AM EST Twist Bioscience Announced Berry Genomics to Offer New NGS Solution to Advance Research and Precision Medicine Benzinga

Feb 18, 2021

12:44PM EST Twist Bioscience Collaborates With Australia Based Specialist Provider For Whole Exome Capture Assay Benzinga

09:15AM EST Twist Bioscience Reports Collaboration With Victorian Clinical Genetic Services On Development Of Novel Whole Exome Capture Diagnostic Assay Benzinga

Feb 17, 2021

07:02PM EST Cathie Wood's ARK Invest Posts Fund Sales For Wednesday, Feb. 17, 2021: GOOGL, CDNA, TWST, VCYT, ONVO, SPLK, SSYS, BYDDY, AVAV, API, PD, PSTG, TCEHY Benzinga

Feb 10, 2021

07:09AM EST Sema4 to Combine with CM Life Sciences to Accelerate Growth Benzinga

Feb 5, 2021

12:32PM EST Baird Maintains Outperform on Twist Bioscience, Raises Price Target to $200 Benzinga

10:03AM EST Benzinga's Top Ratings Upgrades, Downgrades For February 5, 2021 Benzinga

07:44AM EST The Daily Biotech Pulse: J&J Files For COVID-19 Vaccine Approval, Zimmer Biomet's Spin-Off, IPO Deluge Hits Street Benzinga

06:28AM EST JP Morgan Downgrades Twist Bioscience to Underweight, Announces $100 Price Target Benzinga

Feb 4, 2021

05:07PM EST Recap: Twist Bioscience Q1 Earnings Benzinga

04:41PM EST Twist Bioscience Sees FY21 Sales $110M-$118M Vs $116.02M Estimates Benzinga

04:40PM EST Twist Bioscience Q1 EPS $(0.72) Beats $(0.74) Estimate, Sales $28.20M Beat $25.38M Estimate Benzinga

08:35AM EST Earnings Scheduled For February 4, 2021 Benzinga

07:22AM EST The Daily Biotech Pulse: Novartis COVID-19 Drug Readout, Merck And Roche Earnings, 3 IPOs Benzinga

Feb 3, 2021

10:17AM EST Earnings Outlook For Twist Bioscience Benzinga

Jan 30, 2021

01:19PM EST The Week Ahead In Biotech: Merck, Pfizer In Earnings Mix, Plus Adamas, Mallinckrodt FDA Decisions, IPOs And More Benzinga

Jan 22, 2021

07:22AM EST The Daily Biotech Pulse: Fluidigm's Saliva-Based COVID Test Approved In Europe, China Backs Amarin's Vascepa Benzinga

Jan 21, 2021

08:05AM EST The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping Benzinga

Jan 20, 2021

07:32AM EST The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study Benzinga

Jan 19, 2021

08:44AM EST Twist Biosciences Signs Two Biopharma Technology Agreements To 'Enable Novel Therapeutics Discovery' Benzinga

Jan 15, 2021

07:57AM EST The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges Benzinga

Jan 14, 2021

08:04AM EST Twist Bioscience Reports Begun Shipping Its Synthetic RNA Controls For UK Variant Strain Of SARS-CoV-2 Benzinga

Jan 12, 2021

08:16AM EST The Daily Biotech Pulse: GSK, Vir To Start COVID-19 Antibody Study, Novartis In-Licenses BeiGene's Cancer Drug, Earnings Preannouncements Continue Benzinga

Jan 11, 2021

05:14PM EST SKB Finalizes New Lease Agreement With Twist Bioscience Corporation At Recently Reposition Mixed-Use Campus, ParkWorks Industrial Center Benzinga

05:13PM EST SKB finalizes new lease agreement with Twist Bioscience Corporation ("Twist") PR Newswire

Jan 7, 2021

08:18AM EST Twist Bioscience Supplies Centers for Disease Control and Prevention with Custom SARS-CoV-2 Synthetic RNA Controls Benzinga

Jan 4, 2021

11:13AM EST Evercore ISI Group Downgrades Twist Bioscience to In-Line, Raises Price Target to $140 Benzinga

Dec 23, 2020

08:31AM EST The Daily Biotech Pulse: Supernus Issues Positive ADHD Readout, Sorrento Files For Emergency Use Authorization For Rapid COVID-19 Test, Inhibikase To Make Wall Street Debut Benzinga

08:02AM EST Twist Bioscience Reports Will Offer Synthetic RNA Control For UK Varian Strain Of SARS-CoV-2 Benzinga

Dec 22, 2020

07:45AM EST The Daily Biotech Pulse: Ziopharm To Start Blood Cancer Study, Chemocentryx & Soligenix Slump On Adverse Clinical Trial Outcomes Benzinga

Dec 17, 2020

05:26PM EST 12 Emerging Technologies To Watch In 2021 Benzinga

Dec 11, 2020

08:11AM EST The Daily Biotech Pulse: Pfizer-BioNTech Receive FDA Panel Backing, Sanofi-GSK Disclose Delay In Vaccine Program, 4 Biotechs To Debut On Wall Street Benzinga

Dec 10, 2020

08:07AM EST Twist Bioscience Reports Launch Of Clonal-Ready Gene Fragments Benzinga

Dec 8, 2020

10:27AM EST Twist Bioscience Corp. (TWST) shares are on a rise on Tuesday morning trade, as the company announced the closing of its underwritten public offering of 3,211,362 shares of its common stock at a public offering price of $110.00 per share. RTTNews

08:04AM EST The Daily Biotech Pulse: ASH Presentations, Axsome's Positive Midstage Readout, Follow-On Offerings Benzinga

Dec 4, 2020

08:04AM EST The Daily Biotech Pulse: BioCryst's Heredity Angioedema Treatment Clears FDA, Sutro Biopharma Readout, 2 IPOs Benzinga

Dec 1, 2020

04:01PM EST Twist Bioscience Reports $250M Offering Benzinga

Nov 24, 2020

08:13AM EST The Daily Biotech Pulse: Alnylam's Oxluma Snags Early FDA Approval, DBV Chief Scientific Officer To Depart, Decision Day For Liquidia Benzinga

04:14AM EST SVB Leerink Maintains Market Perform on Twist Bioscience, Raises Price Target to $100 Benzinga

Nov 23, 2020

08:56AM EST Twist Bioscience shares were trading higher after the company reported better-than-expected Q4 EPS and sales results. Benzinga

07:54AM EST Twist Bioscience: Q4 Earnings Insights Benzinga

07:16AM EST Twist Bioscience Announces Preclinical Data for SARS-CoV-2 Antibodies Benzinga

07:06AM EST Twist Bioscience Sees FY21 Sales $110M-$118M vs $117.94M Est. Benzinga

07:05AM EST Twist Bioscience Q4 EPS $(0.54) Beats $(0.70) Estimate, Sales $32.40M Beat $22.67M Estimate Benzinga

04:05AM EST Earnings Scheduled For November 23, 2020 Benzinga

Nov 20, 2020

10:04AM EST Earnings Preview for Twist Bioscience Benzinga

08:06AM EST The Daily Biotech Pulse: Amarin Surges On Vascepa Data, Mesoblast Rallies On Novartis Deal, Decision Day For Eiger Benzinga

Nov 19, 2020

08:17AM EST The Daily Biotech Pulse: Aquestive's Positive FDA Meeting, Prevail Awarded Patent, Neuro-Oncology Conference Gets Underway Benzinga

08:01AM EST Twist Bioscience Reports Research Use Only Availability Of First Hybridization Capture-Based Next-Gen Sequencing SARS-CoV-2 Assay For Characterization, Surveillance Of Virus Benzinga

Nov 16, 2020

08:00AM EST Twist Bioscience Reports Continued Partnership With International Genetically Engineered Machine Foundation Benzinga

Nov 13, 2020

07:40AM EST The Daily Biotech Pulse: Urovant In M&A Deal, Sanofi's Binary Event, Conference Presentations Benzinga

Nov 12, 2020

03:16PM EST Twist Bioscience Reports Co., Illumina, Western Digital Form Alliance With Microsoft 'to advance the field of DNA data storage' Benzinga

07:44AM EST The Daily Biotech Pulse: AstraZeneca's Cancer Drug Flunks COVID-19 Studies, Five Prime On a Roll, Morphosys, Xencor, Incyte Strike Cancer Deal Benzinga

Nov 10, 2020

08:40AM EST The Daily Biotech Pulse: Lilly's COVID-19 Antibody Treatment Approved For Emergency Use, Supernus Faces Twin Regulatory Setbacks, Revance, Arena Flunk Midstage Studies Benzinga

Oct 27, 2020

08:14AM EDT Twist Bioscience Announces Collaboration With Beyond Earth To Launch Artwork Stored In DNA Into Space Benzinga

08:08AM EDT Twist Bioscience Reports Collaboration With Beyond Earth To Launch Artwork Stored In DNA Into Space Benzinga

Oct 20, 2020

08:30AM EDT SVB Leerink Initiates Coverage On Twist Bioscience with Market Perform Rating, Announces Price Target of $90 Benzinga

Sep 2, 2020

08:03AM EDT Twist Bioscience Announces 'Potent SARS-CoV-2 Neutralizing Data from COVID-19 Therapeutic Antibody Program' Benzinga

Aug 6, 2020

04:41PM EDT Twist Bioscience Q3 EPS $(0.67) Beats $(0.73) Estimate, Sales $21.20M Beat $14.17M Estimate Benzinga

07:57AM EDT The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO Benzinga

Aug 4, 2020

08:34AM EDT Twist Bioscience Reports Partnership With Seismic bio For Discovery, Optimization Of Antibodies, No Terms Disclosed Benzinga

Jul 28, 2020

11:04AM EDT Why Twist Bioscience's Stock Is Trading Higher Today Benzinga

10:02AM EDT Twist Bioscience shares are trading higher after the company announced the launch of 2 coronavirus antibody panels to expedite research for COVID-19. Benzinga

08:01AM EDT Twist Bioscience Highlights Launch Of 2 Coronavirus Antibody Panels To Expedite Research For COVID-19 Benzinga

Jul 16, 2020

08:18AM EDT Twist Bioscience Reports Partnership With Ivetx To Deliver Antibody Therapeutics For Dogs And Cats Benzinga

Jul 15, 2020

02:26PM EDT Vanderbilt Vaccine Center Publishes Study Titled 'Potently neutralizing and protective human antibodies against SARS-CoV-2' BZ NOTE: Twist Biosciences Is A Supplier Of DNA To Vanderbilt University Benzinga

Share